Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells

Stem Cells

Volumn 35, Issue 4, 2017, Pages 1065-1079

  Cox, Charles S ^a   Hetz, Robert A ^a   Liao, George P ^a   Aertker, Benjamin M ^a   Ewing Cobbs, Linda ^a   Juranek, Jenifer ^a   Savitz, Sean I ^a   Jackson, Margaret L ^a   Romanowska Pawliczek, Anna M ^a   Triolo, Fabio ^a   Dash, Pramod K ^a   Pedroza, Claudia ^a   Lee, Dean A ^b   Worth, Laura ^c   Aisiku, Imoigele P ^d   Choi, Huimahn A ^a   Holcomb, John B ^a   Kitagawa, Ryan S ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Nationwide Children's ^*  (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

adult human bone marrow; adult stem cells; bone marrow stromal cells; cellular therapy; clinical trials; diffusion tensor imaging; traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR; AUTACOID; CYTOKINE;

ADULT; ADVERSE OUTCOME; ARTICLE; BONE MARROW DERIVED MONONUCLEAR CELL; BRAIN SIZE; CELL ISOLATION; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; DOWN REGULATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FRACTIONAL ANISOTROPY; GLASGOW COMA SCALE; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PYRAMIDAL TRACT; THERAPY EFFECT; TRAUMATIC BRAIN INJURY; WHITE MATTER; BEHAVIOR; BLOOD; BONE MARROW CELL; CLINICAL TRIAL; CYTOLOGY; GRAY MATTER; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PHASE 1 CLINICAL TRIAL; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; BEHAVIOR; BIOMARKERS; BONE MARROW CELLS; BRAIN INJURIES, TRAUMATIC; CORPUS CALLOSUM; CYTOKINES; FEMALE; GRAY MATTER; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; MALE; PYRAMIDAL TRACTS; TREATMENT OUTCOME;

EID: 85005790450     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2538     Document Type: Article

References (48)

1. Centers for Disease Control and Prevention. (2015). Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation. Atlanta, GA: National Center for Injury Prevention and Control; Division of Unintentional Injury Prevention.
2. Kraus JF McArthur DL. Epidemiologic aspects of brain injury. Neurol Clin 1996;14:435–450.
3. Savitz SI Cox CS. Jr., Concise review: Cell therapies for stroke and traumatic brain injury: Targeting microglia. Stem Cells 2016;34:537–542.
4. Sharma S, Yang B, Strong R et al. Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke. J Neurosci Res 2010;88:2869–2876.
5. Suda S, Yang B, Schaar K et al. Autologous bone marrow mononuclear cells exert broad effects on short- and long-term biological and functional outcomes in rodents with intracerebral hemorrhage. Stem Cells Dev 2015;24:2756–2766.
6. Bedi SS, Walker PA, Shah SK et al. Autologous bone marrow mononuclear cells therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. J Trauma Acute Care Surg 2013;75:410–416.
7. Yang B, Strong R, Sharma S et al. Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res 2011;89:833–839.
8. Cox CS, Jr, Baumgartner JE, Harting MT et al. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery 2011;68:588–600.
9. Brenneman M, Sharma S, Harting M et al. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab 2010;30:140–149.
10. Savitz SI, Misra V, Kasam M et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol 2011;70:59–69.
11. Fischer UM, Harting MT, Jimenez F et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev 2009;18:683–691.
12. Teasdale G Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;304:81–84.
13. Brain Trauma Foundation B, AANS, CNS, Care ACJSoNaC. Guidelines for the management of severe traumatic brain injury, 3rd edition. J Neurotrauma 2007;24:S1–S106.
14. Antonelli M, Moreno R, Vincent JL et al. Application of SOFA score to trauma patients. Intensive Care Med 1999;25:389–394.
15. Murray JF, Matthay MA, Luce JM et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720–723.
16. Adams JH, Doyle D, Ford I et al. Diffuse axonal injury in head injury: Definition, diagnosis and grading. Histopathology 1989;15:49–59.
17. Salamon N, Sicotte N, Alger J et al. Analysis of the brain-stem white-matter tracts with diffusion tensor imaging. Neuroradiology 2005;47:895–902.
18. Wilde EA, Hunter JV, Newsome MR et al. Frontal and temporal morphometric findings on MRI in children after moderate to severe traumatic brain injury. J Neurotrauma 2005;22:333–344.
19. Bagiella E, Novack TA, Ansel B et al. Measuring outcome in traumatic brain injury treatment trials: Recommendations from the traumatic brain injury clinical trials network. J Head Trauma Rehabil 2010;25:375–382.
20. Ewing-Cobbs L, Prasad MR, Swank P et al. Arrested development and disrupted callosal microstructure following pediatric traumatic brain injury: Relation to neurobehavioral outcomes. NeuroImage 2008;42:1305–1315.
21. Harting MT, Jimenez F, Xue H et al. Intravenous mesenchymal stem cell therapy for traumatic brain injury: Laboratory investigation. J Neurosurg 2009;110:1189–1197.
22. Walker PA, Shah SK, Jimenez F et al. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: Preserving the blood brain barrier via an interaction with splenocytes. Exp Neurol 2010;225:341–352.
23. Anbari F, Khalili MA, Bahrami AR et al. Intravenous transplantation of bone marrow mesenchymal stem cells promotes neural regeneration after traumatic brain injury. Neural Regen Res 2014;9:919–923.
24. Arien-Zakay H, Gincberg G, Nagler A et al. Neurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury. J Neurotrauma 2014;31:1405–1416.
25. Jiang J, Bu X, Liu M et al. Transplantation of autologous bone marrow-derived mesenchymal stem cells for traumatic brain injury. Neural Regen Res 2012;7:46–53.
26. Kim HJ, Lee JH Kim SH. Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: Secretion of neurotrophic factors and inhibition of apoptosis. J Neurotrauma 2010;27:131–138.
27. Li L, Jiang Q, Qu CS et al. Transplantation of marrow stromal cells restores cerebral blood flow and reduces cerebral atrophy in rats with traumatic brain injury: In vivo MRI study. J Neurotrauma 2011;28:535–545.
28. Lu D, Sanberg PR, Mahmood A et al. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 2002;11:275–281.
29. Mahmood A, Lu D Chopp M. Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery 2004;55:1185–1193.
30. Mahmood A, Lu D, Lu M et al. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 2003;53:697–702. discussion −3.
31. Osanai T, Kuroda S, Sugiyama T et al. Therapeutic effects of intra-arterial delivery of bone marrow stromal cells in traumatic brain injury of rats–in vivo cell tracking study by near-infrared fluorescence imaging. Neurosurgery 2012;70:435–444. discussion 44.
32. Pischiutta F, D'amico G, Dander E et al. Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain. Neuropharmacology 2014;79:119–126.
33. Turtzo LC, Budde MD, Dean DD et al. Failure of intravenous or intracardiac delivery of mesenchymal stromal cells to improve outcomes after focal traumatic brain injury in the female rat. PLoS One 2015;10:e0126551.
34. Watanabe J, Shetty AK, Hattiangady B et al. Administration of TSG-6 improves memory after traumatic brain injury in mice. Neurobiol Dis 2013;59:86–99.
35. Zanier ER, Montinaro M, Vigano M et al. Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma. Crit Care Med 2011;39:2501–2510.
36. Zhang R, Liu Y, Yan K et al. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation 2013;10:106.
37. Moll G, Rasmusson-Duprez I, Von Bahr L et al. Are therapeutic human mesenchymal stromal cells compatible with human blood?. Stem Cells 2012;30:1565–1574.
38. Cotton BA, Minei KM, Radwan ZA et al. Admission rapid thrombelastography predicts development of pulmonary embolism in trauma patients. J Trauma Acute Care Surg 2012;72:1470–1477.
39. François M, Copland IB, Yuan S et al. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing. Cytotherapy 2012;14:147–152.
40. Xu Y, McArthur DL, Alger JR et al. Early nonischemic oxidative metabolic dysfunction leads to chronic brain atrophy in traumatic brain injury. J Cereb Blood Flow Metab 2010;30:883–894.
41. Ohtaki H, Ylostalo JH, Foraker JE et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA 2008;105:14638–14643.
42. Sanberg PR, Park D, Kuzmin-Nichols N et al. Monocyte transplantation for neural and cardiovascular ischemia repair. J Cell Mol Med 2010;14:553–563.
43. Loane DJ, Kumar A, Stoica BA et al. Progressive neurodegeneration after experimental brain trauma: Association with chronic microglial activation. J Neuropathol Exp Neurol 2014;73:14–29.
44. Sidaros A, Skimminge A, Liptrot MG et al. Long-term global and regional brain volume changes following severe traumatic brain injury: A longitudinal study with clinical correlates. NeuroImage 2009;44:1–8.
45. Brezova V, Gøran Moen K, Skandsen T et al. Prospective longitudinal MRI study of brain volumes and diffusion changes during the first year after moderate to severe traumatic brain injury. NeuroImage Clin 2014;5:128–140.
46. Trivedi MA, Ward MA, Hess TM et al. Longitudinal changes in global brain volume between 79 and 409 days after traumatic brain injury: Relationship with duration of coma. J Neurotrauma 2007;24:766–771.
47. Ding K, De La Plata CM, Wang JY et al. Cerebral atrophy after traumatic white matter injury: Correlation with acute neuroimaging and outcome. J Neurotrauma 2008;25:1433–1440.
48. Vahidy FS, Rahbar MH, Zhu H et al. Systematic Review and Meta-Analysis of Bone Marrow-Derived Mononuclear Cells in Animal Models of Ischemic Stroke. Stroke 2016;47:1632–1639.